Christopher Jones

Title: Christopher Jones: Innovator in Vascular Research

Introduction

Christopher Jones is a prominent inventor based in Salt Lake City, UT. He has made significant contributions to the field of vascular research, particularly in the development of methods and compositions aimed at inhibiting vascular permeability and pathologic angiogenesis. With a total of 2 patents, his work has the potential to impact various medical conditions related to vascular health.

Latest Patents

Jones' latest patents focus on compositions and methods for inhibiting vascular permeability. The first patent describes compounds, compositions, and methods that can effectively inhibit vascular permeability and pathologic angiogenesis. This includes pharmaceutical compositions that are useful in treating conditions induced by specific angiogenic, permeability, and inflammatory factors such as VEGF, bFGF, and thrombin. The second patent similarly addresses ocular pathologic angiogenesis and vascular permeability, providing methods for producing and screening compounds capable of inhibiting these conditions.

Career Highlights

Christopher Jones is affiliated with the University of Utah Research Foundation, where he continues to advance his research in vascular health. His innovative approaches have garnered attention in the scientific community, contributing to the understanding and treatment of diseases related to vascular permeability.

Collaborations

Some of his notable coworkers include Dean Li and Nyall London, who have collaborated with him on various research projects. Their combined expertise enhances the potential impact of their work in the field.

Conclusion

Christopher Jones is a key figure in the realm of vascular research, with his patents paving the way for new treatments and methods. His contributions are vital for advancing medical science and improving patient outcomes related to vascular conditions.